Kyogo Itoh

Kurume, 8390863, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 74 publications

Exploring the Potential of Humoral Immune Response to Commensal Bifidobacterium as a Biomarker for Human Health, including Both Malignant and Non-Malignant Diseases: A Perspective on Detection Strategies and Future Directions.

Exploring the Potential of Humoral Immune Response to Commensal Bifidobacterium as a Biomarker for Human Health, including Both Malignant and Non-Malignant Diseases: A Perspective on Detection Strategies and Future Directions.

Journal: Biomedicines

Published: October 24, 2023

Evaluation of the Immunological Response of Childhood Cancer Patients Treated with a Personalized Peptide Vaccine for Refractory Soft Tissue Tumor: A Four-Case Series.

Evaluation of the Immunological Response of Childhood Cancer Patients Treated with a Personalized Peptide Vaccine for Refractory Soft Tissue Tumor: A Four-Case Series.

Journal: The Kurume medical journal

Published: May 14, 2023

Immune responses of patients without cancer recurrence after a cancer vaccine over a long term.

Immune responses of patients without cancer recurrence after a cancer vaccine over a long term.

Journal: Molecular and clinical oncology

Published: February 10, 2022

Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer.

Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: September 08, 2020

A randomized phase III trial of personalized peptide vaccination for castration‑resistant prostate cancer progressing after docetaxel.

A randomized phase III trial of personalized peptide vaccination for castration‑resistant prostate cancer progressing after docetaxel.

Journal: Oncology reports

Published: June 06, 2020

Early phase II study of mixed 19-peptide vaccine monotherapy for refractory triple-negative breast cancer.

Early phase II study of mixed 19-peptide vaccine monotherapy for refractory triple-negative breast cancer.

Journal: Cancer science

Published: April 10, 2020

Plasma level of prostate related-antigen peptide-reactive IgG is a prognostic factor of patients with breast cancer treated with personalized peptide vaccines.

Plasma level of prostate related-antigen peptide-reactive IgG is a prognostic factor of patients with breast cancer treated with personalized peptide vaccines.

Journal: Experimental and therapeutic medicine

Published: March 08, 2020

Investigation of factors associated with reduced clinical benefits of personalized peptide vaccination for pancreatic cancer.

Investigation of factors associated with reduced clinical benefits of personalized peptide vaccination for pancreatic cancer.

Journal: Molecular and clinical oncology

Published: February 20, 2020

Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patients.

Identification of biomarkers for personalized peptide vaccination in 2,588 cancer patients.

Journal: International journal of oncology

Published: November 29, 2019

Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial.

Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial.

Journal: Cancer immunology, immunotherapy : CII

Published: January 21, 2019

A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma.

A randomized, double-blind, phase III trial of personalized peptide vaccination for recurrent glioblastoma.

Journal: Neuro-oncology

Published: December 01, 2018

Immunological consequences following splenectomy in patients with liver cirrhosis.

Immunological consequences following splenectomy in patients with liver cirrhosis.

Journal: Experimental and therapeutic medicine

Published: October 06, 2018

Showing 1-12 of 74

Last Updated: 09/26/2026